Literature DB >> 15184869

The Ras-related protein AGS1/RASD1 suppresses cell growth.

Govindan Vaidyanathan1, Mary J Cismowski, Guoshun Wang, Timothy S Vincent, Kevin D Brown, Stephen M Lanier.   

Abstract

AGS1/RASD1 is a Ras-related protein identified as a dexamethasone-inducible cDNA and as a signal regulator in various functional and protein-interaction screens. As an initial approach to define the role of AGS1/RASD1 as a Ras-family member, we determined its influence on cell growth/survival. In clonogenic assays with NIH-3T3 murine fibroblast cells, the MCF-7 human breast cancer cell line and the human lung adenocarcinoma cell line A549, AGS1/RASD1 markedly diminished the number of G418-resistant colonies, whereas the Ras subgroup member K-Ras was without effect. A549 cell infection with adenovirus engineered to express AGS1/RASD1 (Ad.AGS1) inhibited log phase growth in vitro and increased the percentage of cells undergoing apoptosis. The anti-growth action was also observed in vivo as the expression of AGS1/RASD1 inhibited the subcutaneous tumor growth of A549 cells in athymic nude mice. These data indicate that AGS1/RASD1, a member of the Ras superfamily of small G-proteins that often promotes cell growth and tumor expansion, plays an active role in preventing aberrant cell growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184869     DOI: 10.1038/sj.onc.1207774

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

Review 1.  Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time.

Authors:  Nicolas Aznar; Nicholas Kalogriopoulos; Krishna K Midde; Pradipta Ghosh
Journal:  Bioessays       Date:  2016-02-16       Impact factor: 4.345

2.  Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.

Authors:  M Schwendt; J F McGinty
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

3.  Early gene expression in salivary gland after isoproterenol treatment.

Authors:  Yi Zhou; Hung-I H Chen; A L Lin; H Dang; Karin Haack; Shelley A Cole; Yufei Huang; Haiyang Yu; Yidong Chen; Chih-Ko Yeh
Journal:  J Cell Biochem       Date:  2015-03       Impact factor: 4.429

Review 4.  Activators of G protein signaling in the kidney.

Authors:  Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2015-01-27       Impact factor: 4.030

5.  Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.

Authors:  Galina Gritsina; Fang Xiao; Shane W O'Brien; Rashid Gabbasov; Marisa A Maglaty; Ren-Huan Xu; Roshan J Thapa; Yan Zhou; Emmanuelle Nicolas; Samuel Litwin; Siddharth Balachandran; Luis J Sigal; Dennis Huszar; Denise C Connolly
Journal:  Mol Cancer Ther       Date:  2015-02-02       Impact factor: 6.261

6.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

7.  The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning.

Authors:  Lori A Knackstedt; Heather L Trantham-Davidson; Marek Schwendt
Journal:  Addict Biol       Date:  2013-05-27       Impact factor: 4.280

8.  miR-375 maintains normal pancreatic alpha- and beta-cell mass.

Authors:  Matthew N Poy; Jean Hausser; Mirko Trajkovski; Matthias Braun; Stephan Collins; Patrik Rorsman; Mihaela Zavolan; Markus Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

9.  The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Suzanne M Wetz; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Am J Pathol       Date:  2012-11-14       Impact factor: 4.307

10.  Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.

Authors:  Sivakumar Vijayaraghavalu; Josephine Kamtai Dermawan; Venugopalan Cheriyath; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2012-12-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.